medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Número 6

<< Anterior Siguiente >>

Rev Invest Clin 2017; 69 (6)


Abnormal Cardiovascular Findings in Acute Pancreatitis: Are They Associated with Disease Severity?

Chacón-Portillo MA, Payró-Ramírez G, Peláez-Luna MC, Uscanga-Domínguez LF, Vasquéz-Ortiz Z, Orihuela C, Martínez-Vázquez SE, Hernández-Calleros J

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 314-318
Archivo PDF: 70.80 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Agarwal S, George J, Padhan RK, et al. Reduction in mortality in severe acute pancreatitis: A time trend analysis over 16 years. Pancreatology. 2016;16:194-9.

  2. Drummond J. Cardiac abnormalities of abdominal origin. S Afr Med J. 1934;8:520-6.

  3. Rubio-Tapia A, García-Leiva J, Asensio-Lafuente E, Robles-Díaz G, Vargas-Vorácková F. Electrocardiographic abnormalities in patients with acute pancreatitis. J Clin Gastroenterol. 2005; 39:815-8.

  4. Yegneswaran B, Kostis JB, Pitchumoni CS. Cardiovascular manifestations of acute pancreatitis. J Crit Care. 2011;26:225. e11-8.

  5. Bugdaci MS, Oztekin E, Kara E, Koker I, Tufan A. Prognostic value of increased B type natriuretic peptide in cases with acute pancreatitis. Eur J Intern Med. 2012;23:e97-e100.

  6. Pezzilli R, Barassi A, Iammarino MT, d’Eril GM. Is troponin T a useful marker of myocardial damage in acute pancreatitis? A prospective time course study. Dig Liver Dis. 2013;45:347-8.

  7. Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl. 1999;230:132-42.

  8. Nishikimi T, Minamino N, Ikeda M, et al. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure-different proBNP-108 to BNP-32 ratios in atrial and ventricular overload. Heart. 2010;96:432-9.

  9. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197-204.

  10. Saulea A, Costin S, Rotari V. Heart ultrastructure in experimental acute pancreatitis. Rom J Physiol. 1997;34:35-44.

  11. Albrecht CA, Laws FA. ST segment elevation pattern of acute myocardial infarction induced by acute pancreatitis. Cardiol Rev. 2003;11:147-51.

  12. Khairy P, Marsolais P. Pancreatitis with electrocardiographic changes mimicking acute myocardial infarction. Can J Gastroenterol. 2001;15:522-6.

  13. Nadkarni N, Bhasin DK, Rana SS, et al. Diastolic dysfunction, prolonged QTc interval and pericardial effusion as predictors of mortality in acute pancreatitis. J Gastroenterol Hepatol. 2012;27:1576-80.

  14. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62: 102-11.

  15. Talukdar R, Bhattacharrya A, Rao B, Sharma M, Reddy DN. Clinical utility of the revised Atlanta classification of acute pancreatitis in a prospective cohort: Have all loose ends been tied? Pancreatology. 2014;14:257-62.

  16. Talukdar R, Clemens M, Vege SS. Moderately severe acute pancreatitis: Prospective validation of this new subgroup of acute pancreatitis. Pancreas. 2012;41:306-9.

  17. Vege SS, Gardner TB, Chari ST, et al. Low mortality and high morbidity in severe acute pancreatitis without organ failure: A case for revising the Atlanta classification to include “moderately severe acute pancreatitis”. Am J Gastroenterol. 2009; 104:710-5.

  18. Mounzer R, Langmead CJ, Wu BU, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012; 142:1476-82.

  19. Forsmark CE, Baillie J, Practice AG, Economics C, Board AG. AGA institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022-44.

  20. Aundhakar S, Mahajan S, Agarwal A, Mhaskar D. Acute pancreatitis associated with elevated troponin levels: Whether to thrombolyse or not? Ann Med Health Sci Res. 2013; 3 Suppl 1:S50-2.

  21. Dettori JR. Loss to follow-up. Evid Based Spine Care J. 2011; 2:7-10.

  22. Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: How much is too much? Eur J Epidemiol. 2004;19:751-60.




2020     |     www.medigraphic.com